Guardado en:
| Autor principal: | Clift, Ashley Kieran |
|---|---|
| Formato: | Recurso digital |
| Lenguaje: | |
| Publicado: |
Zenodo
2026
|
| Acceso en línea: | https://doi.org/10.5281/zenodo.19006589 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Effects of kefir consumption on gut microbiota and health outcomes in women with polycystic ovary syndrome
por: Merve Esra Çıtar Dazıroğlu, et al.
Publicado: (2024)
por: Merve Esra Çıtar Dazıroğlu, et al.
Publicado: (2024)
The role of diet therapy in insulin resistance in women with polycystic ovary syndrome
por: Semenyna H.B., et al.
Publicado: (2024)
por: Semenyna H.B., et al.
Publicado: (2024)
Childbirth experiences in women with polycystic ovary syndrome: A cohort study
por: Anne Engtrø Husby, et al.
Publicado: (2024)
por: Anne Engtrø Husby, et al.
Publicado: (2024)
The impact of androgens on pregnancy and fetal outcomes in patients with polycystic ovary syndrome
por: Ömer Tammo, et al.
Publicado: (2025)
por: Ömer Tammo, et al.
Publicado: (2025)
Gingival inflammation and leukocyte–endothelium cell interactions in women with polycystic ovary syndrome
por: Cecilia Fabiana Márquez‐Arrico, et al.
Publicado: (2024)
por: Cecilia Fabiana Márquez‐Arrico, et al.
Publicado: (2024)
Metformin use in women with polycystic ovary syndrome ( PCOS ): Opportunities, benefits, and clinical challenges
por: Saeede Saadati, et al.
Publicado: (2025)
por: Saeede Saadati, et al.
Publicado: (2025)
A prospective 12‐month structured weight loss intervention in women with severe obesity and polycystic ovary syndrome: Impact of weight loss on eating behaviors
por: Josefin Kataoka, et al.
Publicado: (2024)
por: Josefin Kataoka, et al.
Publicado: (2024)
Prevalence of functional hypothalamic amenorrhea in a cohort of women referred because of polycystic ovary syndrome
por: Iris Holzer, et al.
Publicado: (2024)
por: Iris Holzer, et al.
Publicado: (2024)
Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
por: Xuelan Li, et al.
Publicado: (2024)
por: Xuelan Li, et al.
Publicado: (2024)
Homocysteine, vitamin B12, and folate circulating levels in women with and without polycystic ovary syndrome: A systematic review and meta-analysis
por: Ulloque-Badaracco, Juan R., et al.
Publicado: (2025)
por: Ulloque-Badaracco, Juan R., et al.
Publicado: (2025)
Evaluating serum anti‐Müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome in Pakistani women
por: Anita Dileep, et al.
Publicado: (2025)
por: Anita Dileep, et al.
Publicado: (2025)
Age and BMI ‐related changes in hormonal profile in women with polycystic ovary syndrome ( PCOS ): Association with infertility
por: Ewa Zabiegło, et al.
Publicado: (2025)
por: Ewa Zabiegło, et al.
Publicado: (2025)
Dyslipidaemia in women with polycystic ovary syndrome referred to a teaching hospital in Cape Town, South Africa
por: Adrian David Marais, et al.
Publicado: (2024)
por: Adrian David Marais, et al.
Publicado: (2024)
Disclosing α‐lactalbumin impact on the intestinal and vaginal microbiota of women suffering from polycystic ovary syndrome
por: Giulia Alessandri, et al.
Publicado: (2024)
por: Giulia Alessandri, et al.
Publicado: (2024)
Validation of mitochondrial biomarkers and immune dynamics in polycystic ovary syndrome
por: Hui‐Hui Shen, et al.
Publicado: (2024)
por: Hui‐Hui Shen, et al.
Publicado: (2024)
Unraveling mitochondrial dysfunction in polycystic ovary syndrome: Pathophysiological insights.
por: Li, Chia-Jung, et al.
Publicado: (2025)
por: Li, Chia-Jung, et al.
Publicado: (2025)
Digital engagement enhances dual GIP / GLP ‐1 receptor agonist and GLP ‐1 receptor agonist efficacy: A retrospective cohort analysis of a digital weight loss service on outcomes and safety
por: Hans Johnson, et al.
Publicado: (2025)
por: Hans Johnson, et al.
Publicado: (2025)
Bisphenol A and polycystic ovary syndrome in human: A systematic review
por: Lorena Ana Mercedes Lara Urbanetz, et al.
Publicado: (2024)
por: Lorena Ana Mercedes Lara Urbanetz, et al.
Publicado: (2024)
Determinants of polycystic ovary syndrome: A matched case–control study
por: Ishwarpreet Kaur, et al.
Publicado: (2024)
por: Ishwarpreet Kaur, et al.
Publicado: (2024)
Impact of insulin sensitization on metabolic and fertility outcomes in women with polycystic ovary syndrome and overweight or obesity—A systematic review, meta‐analysis, and meta‐regression
por: Suhaniya N. S. Samarasinghe, et al.
Publicado: (2024)
por: Suhaniya N. S. Samarasinghe, et al.
Publicado: (2024)
Response: Risk of cancers in women with polycystic ovary syndrome: Cohort study based on health insurance database in South Korea
por: Jin‐Sung Yuk, et al.
Publicado: (2026)
por: Jin‐Sung Yuk, et al.
Publicado: (2026)
Combined liraglutide and metformin therapy in overweight or obese women with polycystic ovary syndrome: A systematic review and meta‐analysis
por: Jing Ling, et al.
Publicado: (2025)
por: Jing Ling, et al.
Publicado: (2025)
Healthcare and research priorities for women with polycystic ovary syndrome in the UK National Health Service: A modified Delphi method
por: Bassel H. Al Wattar, et al.
Publicado: (2024)
por: Bassel H. Al Wattar, et al.
Publicado: (2024)
Association between anti‐Müllerian hormone levels and polycystic ovary syndrome in a general cohort of young women in Japan
por: Natsuki Miyake, et al.
Publicado: (2024)
por: Natsuki Miyake, et al.
Publicado: (2024)
A review on the nexus of autophagy genes from the perspective of polycystic ovary syndrome
por: Arifa Khatun, et al.
Publicado: (2024)
por: Arifa Khatun, et al.
Publicado: (2024)
Diagnosing polycystic ovary syndrome at a tertiary level hospital in Latin America
por: Julieth Alexandra Guzmán López, et al.
Publicado: (2025)
por: Julieth Alexandra Guzmán López, et al.
Publicado: (2025)
Combined contraceptive pills for androgen excess, not for polycystic ovary syndrome in adolescent girls
por: Francis de Zegher, et al.
Publicado: (2024)
por: Francis de Zegher, et al.
Publicado: (2024)
Predictive model of IVF outcomes for polycystic ovarian morphology and polycystic ovary syndrome in GnRH antagonist protocol using AMH ‐ MoM and ovarian sensitivity index
por: Yoo Ra Ko, et al.
Publicado: (2024)
por: Yoo Ra Ko, et al.
Publicado: (2024)
X centromeric drive may explain the prevalence of polycystic ovary syndrome and other conditions
por: Tom Moore
Publicado: (2024)
por: Tom Moore
Publicado: (2024)
Associations between kisspeptin hormone level and its genetic polymorphisms with polycystic ovary syndrome
por: Ziyi Zheng, et al.
Publicado: (2025)
por: Ziyi Zheng, et al.
Publicado: (2025)
Expression of concern: ‘Metabolic response to selenium supplementation in women with polycystic ovary syndrome: A randomized, double‐blind, placebo‐controlled trial’
Publicado: (2024)
Publicado: (2024)
OP07.06: Understanding dysmenorrhea in women with polycystic ovary morphology: a retrospective study
por: P. Romeo, et al.
Publicado: (2024)
por: P. Romeo, et al.
Publicado: (2024)
The impact of androgens on cardiovascular control mechanisms in polycystic ovary syndrome: Recent advances and translational approaches
por: Zoe H. Adams, et al.
Publicado: (2025)
por: Zoe H. Adams, et al.
Publicado: (2025)
Leader vs follower in the tango of polycystic ovary syndrome: Insulin resistance vs androgen excess
por: Francis de Zegher, et al.
Publicado: (2024)
por: Francis de Zegher, et al.
Publicado: (2024)
CPEB1 induces autophagy and promotes apoptosis in ovarian granulosa cells of polycystic ovary syndrome
por: Feilan Xuan, et al.
Publicado: (2024)
por: Feilan Xuan, et al.
Publicado: (2024)
Insulin sensitisation for polycystic ovary syndrome: High‐dose monotherapy versus low‐dose combination
por: Francis de Zegher, et al.
Publicado: (2024)
por: Francis de Zegher, et al.
Publicado: (2024)
Letter to the Editor: Diagnosing polycystic ovary syndrome at a tertiary level hospital in Latin America
por: Hinpetch Daungsupawong, et al.
Publicado: (2025)
por: Hinpetch Daungsupawong, et al.
Publicado: (2025)
Effects of preconceptional vitamin D levels on in vitro fertilization outcomes in infertile patients with polycystic ovary syndrome: A retrospective cohort study
por: Emre Tunçcan, et al.
Publicado: (2024)
por: Emre Tunçcan, et al.
Publicado: (2024)
Higher pre‐pregnancy body mass index was associated with adverse pregnancy and perinatal outcomes in women with polycystic ovary syndrome after a freeze‐all strategy: A historical cohort study
por: Xinyao Hu, et al.
Publicado: (2024)
por: Xinyao Hu, et al.
Publicado: (2024)
Increased miscarriage rate is associated with at least four components of metabolic syndrome in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycle
por: Ziyi Dai, et al.
Publicado: (2024)
por: Ziyi Dai, et al.
Publicado: (2024)
Ejemplares similares
-
Effects of kefir consumption on gut microbiota and health outcomes in women with polycystic ovary syndrome
por: Merve Esra Çıtar Dazıroğlu, et al.
Publicado: (2024) -
The role of diet therapy in insulin resistance in women with polycystic ovary syndrome
por: Semenyna H.B., et al.
Publicado: (2024) -
Childbirth experiences in women with polycystic ovary syndrome: A cohort study
por: Anne Engtrø Husby, et al.
Publicado: (2024) -
The impact of androgens on pregnancy and fetal outcomes in patients with polycystic ovary syndrome
por: Ömer Tammo, et al.
Publicado: (2025) -
Gingival inflammation and leukocyte–endothelium cell interactions in women with polycystic ovary syndrome
por: Cecilia Fabiana Márquez‐Arrico, et al.
Publicado: (2024)